Literature DB >> 343803

Improved immune-suppression techniques for the exongrafting of human tumours.

G G Steel, V D Courtenay, A Y Rostom.   

Abstract

The transplantability of a xenografted human adenocarcinoma has been examined in mice that had been immune-suppressed by thymectomy and whole-body irradiation and the results have been compared with transplantation into athymic (nude) mice. Two alternative techniques were used to prevent marrow failure following whole-body irradiation: reconstituting the animals with a marrow graft, or protecting them by an injection of cytosine arabinoside (Ara-C) 2 days before the irradiation. The results show that the Ara-C-prepared mice were more receptive to transplantation than marrow-grafted or nude mice, and they were the only animals that developed regional metastases from implanted xenografts. Some recovery of immunity occurred in both types of immune-suppressed mice, which was evident more than 5 weeks after immune-suppression and which was more marked in females than in males. It was concluded that the immune-suppressed mice were superior to nude mice for short-term experiments but they may be less satisfactory for long-term experiments.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343803      PMCID: PMC2009576          DOI: 10.1038/bjc.1978.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  5 in total

1.  In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft.

Authors:  V D Courtenay; I E Smith; M J Peckham; G G Steel
Journal:  Nature       Date:  1976-10-28       Impact factor: 49.962

2.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice.

Authors:  L Kopper; G G Steel
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

3.  Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.

Authors:  J L Millar; B N Hudspith; N M Blackett
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

4.  The growth kinetics of xenografts of human colorectal tumours in immune deprived mice.

Authors:  R G Pickard; L M Cobb; G G Steel
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

5.  The influence of fibrin formation on the transplantability of murine tumour cells: implications for the mechanism of the Révész effect.

Authors:  L J Peters; H B Hewitt
Journal:  Br J Cancer       Date:  1974-04       Impact factor: 7.640

  5 in total
  57 in total

1.  Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.

Authors:  B Maurer-Schultze; I D Bassukas; M Böswald; M Harasim
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  How can grafted breast cancer models be optimized?

Authors:  Séverine Mollard; Yoanne Mousseau; Yasser Baaj; Laurence Richard; Jeanne Cook-Moreau; Jacques Monteil; Benoît Funalot; Franck G Sturtz
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

3.  Hypothesis: when is a seminoma not a seminoma?

Authors:  D Raghavan; E Heyderman; P Monaghan; J Gibbs; E Ruoslahti; M J Peckham; A M Neville
Journal:  J Clin Pathol       Date:  1981-02       Impact factor: 3.411

Review 4.  Studying lung cancer in the laboratory: 1--Development of model systems.

Authors:  R J Fergusson; J F Smyth
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

Review 5.  Human tumor xenografts as model for drug testing.

Authors:  J Mattern; M Bak; E W Hahn; M Volm
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

6.  Temporal morphologic changes in human colorectal carcinomas following xenografting.

Authors:  D H Barkla; P J Tutton
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

7.  Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).

Authors:  A C Jones; P A Wilson; G G Steel
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.

Authors:  J M Pelham; J D Gray; G R Flannery; M V Pimm; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison.

Authors:  A J Shorthouse; M J Peckham; J F Smyth; G G Steel
Journal:  Br J Cancer Suppl       Date:  1980-04

10.  Growth and characterization of multicellular tumor spheroids of human bladder carcinoma origin.

Authors:  C Erlichman; I F Tannock
Journal:  In Vitro Cell Dev Biol       Date:  1986-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.